Ironwood Cancer and Research Centers Chandler Ii — Chandler, Arizona

Ironwood Cancer and Research Centers Chandler Ii is a clinical research site located in Chandler, Arizona, United States 85224-5665.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Ironwood Cancer and Research Centers Chandler Ii has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, HR+/HER2- Breast Cancer.

Sponsors: BeOne Medicines.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chandler

Browse all research sites in Arizona · View every site in Chandler

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ironwood Cancer and Research Centers Chandler Ii?

Ironwood Cancer and Research Centers Chandler Ii has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ironwood Cancer and Research Centers Chandler Ii conducted?

Ironwood Cancer and Research Centers Chandler Ii has 2 clinical trials on record, with 2 currently active. Their work covers Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, HR+/HER2- Breast Cancer.

Is Ironwood Cancer and Research Centers Chandler Ii accredited by Crixeo Clinical Trials?

Ironwood Cancer and Research Centers Chandler Ii has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ironwood Cancer and Research Centers Chandler Ii?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.